| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Design Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 415,000 | 01 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | 01 Feb 2023 | 1 | $0 | 4 | President and CEO, Director | 03 Feb 2023, 15:39 |
| DSGN | Design Therapeutics, Inc. | 19 Dec 2022 | 2 | +$62,503 | 4 | President and CEO, Director | 21 Dec 2022, 16:00 |
| DSGN | Design Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | President and CEO, Director | 02 Feb 2022, 18:50 |